Skip to main content
Full access
Letter to the Editor
Published Online: 1 December 2000

Sildenafil and Erectile Dysfunction

To the Editor: Sildenafil is an oral agent that improves erectile functioning by inhibiting phosphodiesterase in the penis’s vasculature, thereby prolonging the effects of cyclic GMP on smooth muscle tissue (1). Sildenafil is generally well tolerated, although possible side effects include headache, flushing, visual changes, and potentiation of the hypotensive effects of nitrates. Clinical investigators suggest that erectile dysfunction induced by selective serotonin reuptake inhibitors responds to treatment with sildenafil (2, 3). Although they are less well studied, neuroleptics are also associated with impaired erectile functioning (4). We report a case of haloperidol-associated erectile dysfunction remedied by sildenafil therapy.
Mr. A was a 52-year-old male veteran with a long history of schizoaffective disorder and intermittent cocaine abuse who reported erectile dysfunction over the past 2 decades while he was taking neuroleptics, including perphenazine, trifluoperazine, fluphenazine, and haloperidol. Because of erectile dysfunction, he frequently discontinued the neuroleptics. Sexual functioning invariably improved after he stopped taking them. Mr. A had no other systemic diseases, including diabetes, hypertension, peripheral vascular disease, or alcoholism, that affected erectile functioning. His medications for the last 4 months included haloperidol decanoate, 150 mg i.m. every 4 weeks, and benztropine, 1 mg b.i.d. Mr. A reported difficulty attaining and maintaining erections. He could achieve only partial erections that lasted less than a minute. He was interested in having sex, although he felt frustrated by his inability to maintain erections. For his erectile difficulties, we prescribed sildenafil, 50 mg. With sildenafil therapy, he was able to attain a complete erection and experience intercourse without difficulty. In fact, the first time he took sildenafil, he experienced three erections in a 5-hour period. He has successfully used the same dose of sildenafil approximately 20 times with satisfactory results. He reported no side effects, such as headaches, gastrointestinal disturbance, priapism, or visual disturbances.
In this patient, haloperidol-associated erectile dysfunction was alleviated by sildenafil therapy. The mechanism through which haloperidol induces erectile dysfunction is uncertain, although dopamine antagonism and a higher than normal prolactin level are implicated. Sildenafil appears to counteract haloperidol-associated erectile dysfunction, even though the mechanism may be unrelated. It is unknown if cocaine use contributed to any of the patient’s erectile difficulties, although this possible pathology also responded to treatment with sildenafil. The improved treatment of haloperidol-associated sexual side effects may lead to improved compliance with neuroleptics and a more successful treatment of psychosis. Further clinical investigation, using sildenafil to treat sexual dysfunction associated with the use of haloperidol or other antipsychotics, is warranted.

References

1.
Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C: Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8:47–52
2.
Balon R: Fluvoxamine-induced erectile dysfunction responding to sildenafil. J Sex Marital Ther 1998; 24:313–317
3.
Fava M, Rankin MA, Alpert JE, Nierenberg AA, Worthington JJ: An open trial of oral sildenafil in antidepressant-induced sexual dysfunction. Psychother Psychosom 1998; 67:328–331
4.
Aizenberg D, Zemishlany Z, Dorfman-Etrog P, Weizman A: Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 1995; 56:137–141

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 2055-a - 2056

History

Published online: 1 December 2000
Published in print: December 2000

Authors

Affiliations

LAWRENCE A. LABBATE, M.D.
Charleston, S.C.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share